Viewing Study NCT01349569


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2026-01-22 @ 4:01 PM
Study NCT ID: NCT01349569
Status: COMPLETED
Last Update Posted: 2019-01-15
First Post: 2011-05-05
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Allogeneic GM-CSF Vaccine and Lenalidomide in Treating Myeloma Patients With Near Complete Remission
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords: